Thirona, global experts in AI-powered lung image analysis, and VIDA Diagnostics, the clinical imaging intelligence leader announced a strategic partnership at the European Respiratory Society (ERS) meeting in Amsterdam. This collaboration will make Thirona’s advanced quantitative analyses available to a wider network of trial sponsors through VIDA’s Intelligence Platform.

By integrating Thirona’s AI-powered analyses with VIDA’s trial imaging management solution, trial sponsors can gain advanced insights and streamline the entire clinical trial pathway with objective, quantitative measurements.

As Eva van Rikxoort, PhD, CEO and Founder of Thirona, said, “VIDA’s approach to trial imaging management and their extensive global network of sites enables us to bring our advanced analysis to clinical trial sponsors with exceptional quality control and scale.”

This strategic alignment reinforces both Thirona’s and VIDA’s strong commitment to leveraging clinically impactful, AI-powered technology to advance clinical trials, ultimately leading to better and faster patient care.